The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N'-(1,3-diphenyl-1H-pyrazol-5-yl)-N-methyl-propanimidamide ID: ALA1270592
PubChem CID: 52940872
Max Phase: Preclinical
Molecular Formula: C19H20N4
Molecular Weight: 304.40
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC/C(=N\c1cc(-c2ccccc2)nn1-c1ccccc1)NC
Standard InChI: InChI=1S/C19H20N4/c1-3-18(20-2)21-19-14-17(15-10-6-4-7-11-15)22-23(19)16-12-8-5-9-13-16/h4-14H,3H2,1-2H3,(H,20,21)
Standard InChI Key: UGUCKYHPXPFIMG-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
4.0033 -5.5529 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8293 -5.4638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9918 -4.6617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2865 -4.2538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6676 -4.8109 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2835 -3.4259 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9564 -4.3992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9577 -3.5724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2478 -3.1606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5295 -3.5732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5297 -4.3977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2442 -4.8101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2546 -6.1736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8486 -6.8956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2732 -7.6049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1014 -7.5919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5032 -6.8636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0763 -6.1573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9959 -3.0112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9930 -2.1870 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7053 -1.7723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7112 -3.4208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4235 -3.0062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4 5 1 0
7 8 2 0
5 1 1 0
8 9 1 0
1 2 2 0
13 14 2 0
9 10 2 0
14 15 1 0
4 6 1 0
15 16 2 0
10 11 1 0
16 17 1 0
11 12 2 0
17 18 2 0
18 13 1 0
12 7 1 0
6 19 2 0
2 13 1 0
19 20 1 0
2 3 1 0
20 21 1 0
3 4 2 0
19 22 1 0
5 7 1 0
22 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 304.40Molecular Weight (Monoisotopic): 304.1688AlogP: 4.20#Rotatable Bonds: 4Polar Surface Area: 42.21Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.85CX LogP: 4.27CX LogD: 3.71Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.58Np Likeness Score: -1.11
References 1. Cheng KM, Huang YY, Huang JJ, Kaneko K, Kimura M, Takayama H, Juang SH, Wong FF.. (2010) Synthesis and antiproliferative evaluation of N,N-disubstituted-N'-[1-aryl-1H-pyrazol-5-yl]-methnimidamides., 20 (22): [PMID:20855206 ] [10.1016/j.bmcl.2010.08.133 ]